Terms: = Bone cancer AND TNFAIP3, TNFA1P2, 7128, ENSG00000118503, OTUD7C, MGC138687, MGC104522, A20, MGC138688, P21580 AND Diagnosis
7 results:
1. A non-small cell lung carcinoma patient responded to crizotinib therapy after alectinib-induced interstitial lung disease.
Sun W; Zheng J; Zhou J; Zhou J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 52(5):583-587. PubMed ID: 37899398
[TBL] [Abstract] [Full Text] [Related]
2. Screening of osteoarthritis diagnostic markers based on immune-related genes and immune infiltration.
Yuan WH; Xie QQ; Wang KP; Shen W; Feng XF; Liu Z; Shi JT; Zhang XB; Zhang K; Deng YJ; Zhou HY
Sci Rep; 2021 Mar; 11(1):7032. PubMed ID: 33782454
[TBL] [Abstract] [Full Text] [Related]
3. Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance.
Varettoni M; Zibellini S; Defrancesco I; Ferretti VV; Rizzo E; Malcovati L; Gallì A; Porta MGD; Boveri E; Arcaini L; Candido C; Paulli M; Cazzola M
Haematologica; 2017 Dec; 102(12):2077-2085. PubMed ID: 28983055
[TBL] [Abstract] [Full Text] [Related]
4. a20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands.
Chanudet E; Ye H; Ferry J; Bacon CM; Adam P; Müller-Hermelink HK; Radford J; Pileri SA; Ichimura K; Collins VP; Hamoudi RA; Nicholson AG; Wotherspoon AC; Isaacson PG; Du MQ
J Pathol; 2009 Feb; 217(3):420-30. PubMed ID: 19006194
[TBL] [Abstract] [Full Text] [Related]
5. Novel ligands for cancer diagnosis: selection of peptide ligands for identification and isolation of B-cell lymphomas.
McGuire MJ; Samli KN; Chang YC; Brown KC
Exp Hematol; 2006 Apr; 34(4):443-52. PubMed ID: 16569591
[TBL] [Abstract] [Full Text] [Related]
6. A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review).
Kasimir-Bauer S; Oberhoff C; Schindler AE; Seeber S
Int J Oncol; 2002 May; 20(5):1027-34. PubMed ID: 11956600
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use?
Kasimir-Bauer S; Oberhoff C; Sliwinska K; Neumann R; Schindler AE; Seeber S
Breast Cancer Res Treat; 2001 Sep; 69(2):123-32. PubMed ID: 11759818
[TBL] [Abstract] [Full Text] [Related]
